[1] 《中国心血管健康与疾病报告》2021(冠心病部分内容) [J]. 心肺血管病杂志, 2022, 41(12): 1205-1211. [2] 张廷杰, 徐俊波, 黄刚. 医学研究的典范:Framingham心脏研究70年回顾 [J]. 中华心血管病杂志, 2020, 48(9): 805-810. [3] ARONOW W S. Hypertension and left ventricular hypertrophy [J]. Ann Transl Med, 2017, 5(15): 310. [4] 束长城, 魏万林. 高血压左心室肥厚的形成机制研究进展 [J]. 中国循证心血管医学杂志, 2018, 10(6): 760-762. [5] PALMIERO P, ZITO A, MAIELLO M, et al. Left ventricular diastolic function in hypertension: methodological considerations and clinical implications [J]. J Clin Med Res, 2015, 7(3): 137-144. [6] TIRANDI A, CARBONE F, MONTECUCCO F, et al. The role of metabolic syndrome in sudden cardiac death risk: recent evidence and future directions [J]. Eur J Clin Invest, 2022, 52(2): e13693. [7] SALAZAR M R, CARBAJAL H A, ESPECHE W G, et al. Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals [J]. Nutr Metab Cardiovasc Dis, 2017, 27(4): 366-373. [8] WANG Y, YANG W, JIANG X. Association between triglyceride-glucose index and hypertension: a meta-analysis [J]. Front Cardiovasc Med, 2021, 8: 644035. [9] ZHAO S, YU S, CHI C, et al. Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study [J]. Cardiovasc Diabetol, 2019, 18(1): 95. [10] 中国高血压防治指南修订委员会, 高血压联盟(中国), 中华医学会心血管病学分会中国医师协会高血压专业委员会, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1):24-56. [11] NAGUEH S F, SMISETH O A, APPLETON C P, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging [J]. Eur Heart J Cardiovasc Imaging, 2016, 17(12): 1321-1360. [12] POULSEN S H, ANDERSEN N H, IVARSEN P I, et al. Doppler tissue imaging reveals systolic dysfunction in patients with hypertension and apparent "isolated" diastolic dysfunction [J]. J Am Soc Echocardiogr, 2003, 16(7): 724-731. [13] GU J, YIN Z F, ZHANG H L, et al. Characteristics and outcomes of transitions among heart failure categories: a prospective observational cohort study [J]. ESC Heart Fail, 2020, 7(2): 616-625. [14] DEFRONZO R A, TOBIN J D, ANDRES R. Glucose clamp technique: a method for quantifying insulin secretion and resistance [J]. Am J Physiol, 1979, 237(3): E214-E223. [15] TAM C S, XIE W, JOHNSON W D, et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps [J]. Diabetes care, 2012, 35(7): 1605-1610. [16] XIE H, SONG J, SUN L, et al. Independent and combined effects of triglyceride-glucose index on prehypertension risk: a cross-sectional survey in China [J]. J Hum Hypertens, 2021, 35(3): 207-214. [17] KARCZ-SOCHA I, ZWIRSKA-KORCZALA K, ZEMBALA M, et al. Ghrelin PYY 3-36 serum changes in left ventricular hypertrophic, insulin-resistant, hypertensive obese patients [J]. Obes Facts, 2011, 4(5): 386-392. [18] TAN C, WANG A, LIU C, et al. Puerarin improves vascular insulin resistance and cardiovascular remodeling in salt-sensitive hypertension [J].Am J Chin Med, 2017, 45(6): 1169-1184. [19] MADONNA R, PIERAGOSTINO D, ROSSI C, et al. Simulated hyperglycemia impairs insulin signaling in endothelial cells through a hyperosmolar mechanism [J].Vascul Pharmacol, 2020, 130: 106678. [20] 唐昱, 盛国太, 葛郁芝, 等. 高血压左心室肥厚患者结缔组织生长因子和B型钠尿肽的变化及临床意义[J]. 中华老年心脑血管病杂志, 2011, 13(2): 119-121. [21] 陈源源. 围绝经期高血压[J]. 中华老年心脑血管病杂志, 2017, 19(6): 670-672. [22] 王葛, 赵力, 李田昌. 探讨不同性别老年冠心病患者临床特点及危险因素[J]. 中华老年心脑血管病杂志, 2019, 21(5): 483-486. |